When else are beauty deals this good? We tested the products, checked the prices, and scoured hundreds of markdowns to find ...

Merck demonstrates excellence across the board through its resilient revenue mix, expanding profitability, and stellar ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

The 9.7% increase in the cost of Medicare Part B premiums for 2026 is due to several factors, including projected growth in ...

Merck , known as MSD outside the United States and Canada, has been notified that Tutanota LLC (Tutanota) has commenced an unsolicited "mini-tender" offer, dated November 10, 2025, to purchase up to 1 ...

Valo will use its trove of patient records and biobank samples to pinpoint potential targets for Merck’s pipeline expansion.

But then came news of Merck 's ( MRK 1.32%) plans to acquire Cidara for $221.50 per share, or a 109% premium to its prior ...

Merck has bullish valuation metrics and is trading above its 30-week EMA with bullish long-term momentum. Learn why MRK stock ...

The once-daily oral medication, which targets the PCSK9 protein in the liver, has shown the ability to reduce LDL cholesterol levels by nearly 60 percent in clinical trials, according to results ...